You are here

Saint Luke's signs cancer trial agreement with hospital with National Cancer Institute designation

Saint Luke’s Health System has signed an agreement with Washington University’s Alvin J. Siteman Cancer Center that will give its patients access to National Cancer Institute trials for new treatments. 

Dr. Timothy Pluard, the medical director of the Saint Luke’s Cancer Institute, said the partnership will allow Saint Luke’s patients to access about 175 trials of investigational treatments and 35 other population health studies run by Siteman, while under the care of their local Saint Luke’s doctors. 

Read the Kansas City Star's full story here. 

Read the Kansas City's Business Journal's full story here.